These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35677061)

  • 21. Characterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profiling.
    Billingsley JM; Rajakumar PA; Connole MA; Salisch NC; Adnan S; Kuzmichev YV; Hong HS; Reeves RK; Kang HJ; Li W; Li Q; Haase AT; Johnson RP
    PLoS Pathog; 2015 Mar; 11(3):e1004740. PubMed ID: 25768938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sepsis-induced changes in differentiation, maintenance, and function of memory CD8 T cell subsets.
    Heidarian M; Griffith TS; Badovinac VP
    Front Immunol; 2023; 14():1130009. PubMed ID: 36756117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity.
    Boudousquié C; Danilo M; Pousse L; Jeevan-Raj B; Angelov GS; Chennupati V; Zehn D; Held W
    J Immunol; 2014 Sep; 193(6):2784-91. PubMed ID: 25127860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory CD8+ T cell differentiation.
    Obar JJ; Lefrançois L
    Ann N Y Acad Sci; 2010 Jan; 1183():251-66. PubMed ID: 20146720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.
    Intlekofer AM; Takemoto N; Kao C; Banerjee A; Schambach F; Northrop JK; Shen H; Wherry EJ; Reiner SL
    J Exp Med; 2007 Sep; 204(9):2015-21. PubMed ID: 17698591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression.
    Ghiglione Y; Falivene J; Ruiz MJ; Laufer N; Socías ME; Cahn P; Giavedoni L; Sued O; Gherardi MM; Salomón H; Turk G
    PLoS One; 2014; 9(8):e104235. PubMed ID: 25093660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
    Tomiyama H; Matsuda T; Takiguchi M
    J Immunol; 2002 Jun; 168(11):5538-50. PubMed ID: 12023349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of Tissue-Specific CD8
    Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
    J Virol; 2018 May; 92(10):. PubMed ID: 29514902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-specific CD8+ memory stem T cells generated from human peripheral blood effectively eradicate allogeneic targets in mice.
    Guan L; Li X; Wei J; Liang Z; Yang J; Weng X; Wu X
    Stem Cell Res Ther; 2018 Dec; 9(1):337. PubMed ID: 30526661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets.
    Aandahl EM; Sandberg JK; Beckerman KP; Taskén K; Moretto WJ; Nixon DF
    J Immunol; 2003 Mar; 170(5):2349-55. PubMed ID: 12594257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High initial frequency of TCR-transgenic CD8 T cells alters inflammation and pathogen clearance without affecting memory T cell function.
    Wirth TC; Pham NL; Harty JT; Badovinac VP
    Mol Immunol; 2009 Nov; 47(1):71-8. PubMed ID: 19195704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo.
    Kamimura D; Bevan MJ
    J Exp Med; 2007 Aug; 204(8):1803-12. PubMed ID: 17664293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of IL-21, IL-7, and IL-15 conditioned media for expansion of antigen-specific CD8+ T cells from healthy donor-PBMCs suitable for immunotherapy.
    Chamucero-Millares JA; Bernal-Estévez DA; Parra-López CA
    Cell Immunol; 2021 Feb; 360():104257. PubMed ID: 33387685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The requirement of linker for activation of T cells in the primary and memory responses of CD8 T cells.
    Ou-Yang CW; Zhu M; Sullivan SA; Fuller DM; Zhang W
    J Immunol; 2013 Mar; 190(6):2938-47. PubMed ID: 23401587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential in vivo persistence of two subsets of memory phenotype CD8 T cells defined by CD44 and CD122 expression levels.
    Walzer T; Arpin C; Beloeil L; Marvel J
    J Immunol; 2002 Mar; 168(6):2704-11. PubMed ID: 11884436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PSGL-1 Is a T Cell Intrinsic Inhibitor That Regulates Effector and Memory Differentiation and Responses During Viral Infection.
    Tinoco R; Neubert EN; Stairiker CJ; Henriquez ML; Bradley LM
    Front Immunol; 2021; 12():677824. PubMed ID: 34326837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8
    Mellouk A; Bobé P
    FASEB J; 2019 Mar; 33(3):3225-3236. PubMed ID: 30383448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8+ memory T lymphocytes from bone marrow--immune function and therapeutic potential.
    Wood AH; Zhang X; Farber DL; Strome SE
    Crit Rev Immunol; 2007; 27(6):527-37. PubMed ID: 18197798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.